Similar articles

• Inhibitors of urease as chemotherapeutic agents.

  Rosenstein IJ, Hamilton-Miller JM. Rosenstein IJ, et al. Crit Rev Microbiol. 1984;11(1):1-12. doi: 10.3109/10408418409105901. Crit Rev Microbiol. 1984. PMID: 6373150 Review. No abstract available.
• Jack bean urease (EC 3.5.1.5). Demonstration of a carbamoyl-transfer reaction and inhibition by hydroxamic acids.

  Blakeley RL, Hinds JA, Kunze HE, Webb EC, Zerner B. Blakeley RL, et al. Biochemistry. 1969 May;8(5):1991-2000. doi: 10.1021/bi00833a032. Biochemistry. 1969. PMID: 5785219 No abstract available.
• [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].

  Lorenz J, Lorenz K, Dabrowska B, Kowal R. Lorenz J, et al. Z Urol Nephrol. 1989 Dec;82(12):685-9. Z Urol Nephrol. 1989. PMID: 2698024 German.
• Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.

  Griffith DP, Gibson JR, Clinton CW, Musher DM. Griffith DP, et al. J Urol. 1978 Jan;119(1):9-15. doi: 10.1016/s0022-5347(17)57366-8. J Urol. 1978. PMID: 23442
• Urea and urease.

  Andrews RK, Blakeley RL, Zerner B. Andrews RK, et al. Adv Inorg Biochem. 1984;6:245-83. Adv Inorg Biochem. 1984. PMID: 6398964 Review. No abstract available.